Work Package 8 (WP8) ensures that GREG’s impact lasts long-term and that Real-World Evidence (RWE) is successfully adopted beyond the project’s lifespan.
Co-led by the European Society of Cardiology (ESC) and Sanofi, WP8 is dedicated to making sure that GREG’s groundbreaking guidance, tools, and recommendations reach and resonate with regulators, Health Technology Assessment (HTA) bodies, healthcare professionals, industry partners, patients, and the general public.
Real-World Evidence holds immense potential to accelerate access to safe, effective, and cost-efficient medicines and medical devices for European citizens. However, its real-world impact depends on widespread awareness, understanding, and adoption among key stakeholders.
To achieve this, WP8 drives key activities across several fronts:
- Dissemination and Communication: WP8 develops a multi-channel outreach strategy (including the official website, social media, newsletters, and press releases) to share GREG’s progress and successes. It organizes scientific sessions at ESC Congresses, webinars, and policy briefings to highlight the value of RWE in decision-making, while publishing lay summaries and podcasts to engage diverse audiences.
- Training and Education: WP8 creates targeted training programs for stakeholders on how to effectively use GREG’s guidance and tools, leveraging the GetReal platform to host and sustain these educational materials post-project.
- Sustainability and Exploitation: WP8 designs a robust Exploitation and Sustainability Plan to ensure GREG’s outputs remain relevant, accessible, and regularly updated, identifying key partners, networks, and funding mechanisms to maintain living guidance, tools, and data networks.
As GREG progresses into its second year, WP8 is ramping up its efforts to engage, educate, and empower stakeholders. Key initiatives on the horizon include launching the first GREG Webinar Series to deep-dive into RWE methodologies and regulatory applications, developing policy briefs for Members of the European Parliament (MEPs) to support EU health policies, and collaborating closely with WP7 to produce patient-friendly materials that demystify RWE for non-experts.
WP8’s work is pivotal to GREG’s vision of a Europe where RWE is seamlessly integrated into healthcare decision-making. By disseminating knowledge, fostering practical skills, and ensuring long-term sustainability, WP8 helps unlock the full potential of RWE, leading to faster access to innovations, better-informed decisions, and improved health outcomes for all Europeans.
WP8 is led by the European Society of Cardiology and Sanofi, with essential contributions from the GetReal Institute, WL Gore & Associates, EUPATI, Novo Nordisk, the Aragonese Institute for Health Sciences, the University of Oxford, Medtronic, the EHDEN Foundation, and SYNAPSE Research Management Partners.
“At WP8, we aim to ensure that GREG’s impact extends far beyond the project itself. By sharing knowledge and project outputs and engaging different stakeholders, we help promote a better understanding and wider uptake of Real-World Evidence in healthcare decision-making. Through communication, training, and sustainability planning, WP8 works to keep GREG’s outputs accessible and relevant, contributing to more informed decisions and a better use of evidence in healthcare across Europe and beyond. “- Alejandro Puigrefagut Pla, WP8 lead from European Society of Cardiology
“In WP8, we are committed to bring innovation in RWE methods to all stakeholders including regulators, payers, healthcare providers, patients, researchers and industry through huge communication and training programs. We collaborate on a daily basis with all other WPs to build the most relevant and up to date content.” – Stéphanie Tcherny – Lessenot, WP8 Lead from Sanofi

